Skip to content

Comparison of the effectiveness of Ichthammol glycerine,Heparinoid application and Magsulph glycerine application on the reduction of infusion related inflammation of the vein

Comparative efficacy, safety and pharmaco-economic evaluation of dressing with â??heparinoid preparationâ??, â??Magnesium Sulphate-glycerineâ?? and â??Ichthammol glycerineâ?? on phlebitis following peripheral intravenous cannulation: A double blinded randomized clinical trial,ACC, PGIMER, Chandigarh

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/12/004245
Enrollment
120
Registered
2013-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Phlebitis following peripheral intravenous cannulation

Interventions

Intervention1: Ichthammol glycerine: 3-5 ml of ichthammol glycerine will be taken for doing dressing on the affected site .Ichthammol glycerine local application will be done 2 times/day (12 hrsly)for

Sponsors

Dr Sukhpal Kaur
Lead Sponsor
Dr Bikash Medhi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted in ACC,PGIMER,Chandigarh and develop phlebitis as the result of intravenous therapy. •Patients with visual infusion phlebitis score of two or more •Patients with infusion related phlebitis and not received any form of intervention by the staff •Patients who develop phlebitis only on the upper limbs.

Exclusion criteria

Exclusion criteria: The patient/ legally acceptable representatives who are not willing to participate the study - Patients who will be receiving chemotherapeutic agents •Patients with central venous catheter on the same limb. •Patients with dermatological disorders. •Patients with any bleeding disorders,injury to the same limb,pre-existing lymphatic obstruction. •Patients who are allergic to heparinoid or ichthammol glycerine or magsulph - glycerine

Design outcomes

Primary

MeasureTime frame
Study result helps in the provision of the most effective intervention for the management of post infusion intravenous cannulation phlebitisTimepoint: 6 weeks

Secondary

MeasureTime frame
Study result helps in the provision of the most pharmacoeconomic intervention for the management of post infusion intravenous cannulation phlebitisTimepoint: 6 weeks

Countries

India

Contacts

Public ContactBidisha Basu

PGIMER

drbikashus@yahoo.com91-172-2755250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026